Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer

Genome Research

Volumn 21, Issue 7, 2011, Pages 1028-1041

  Kim, Jung H ^a   Dhanasekaran, Saravana M ^a   Prensner, John R ^a   Cao, Xuhong ^a   Robinson, Daniel ^a   Kalyana Sundaram, Shanker ^a,b   Huang, Christina ^a   Shankar, Sunita ^a   Jing, Xiaojun ^a   Iyer, Matthew ^a   Hu, Ming ^a,e   Sam, Lee ^a   Grasso, Catherine ^a   Maher, Christopher A ^a   Palanisamy, Nallasivam ^a   Mehra, Rohit ^a   Kominsky, Hal D ^a   Siddiqui, Javed ^a   Yu, Jindan ^c   Qin, Zhaohui S ^d   Chinnaiyan, Arul M ^a   more..

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b BHARATHIDASAN UNIVERSITY   (India)

^c NORTHWESTERN UNIVERSITY   (United States)

^d EMORY UNIVERSITY   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; BENIGN TUMOR; CANCER CELL; CANCER GROWTH; DNA METHYLATION; DNA MODIFICATION; DNA SEQUENCE; EPIGENETICS; GENE MAPPING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; SEQUENCE ANALYSIS;

CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; EPIGENOMICS; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENE LIBRARY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MARKOV CHAINS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROSTATE; PROSTATIC NEOPLASMS; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION INITIATION SITE;

EID: 79959911384     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.119347.110     Document Type: Article

References (59)

1. Ashida S, Nakagawa H, Katagiri T, Furihata M, Iiizumi M, Anazawa Y, Tsunoda T, Takata R, Kasahara K, Miki T, et al. 2004. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: Genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res 64: 5963-5972. (Pubitemid 39129392)
2. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, Sboner A, Esgueva R, Pflueger D, Sougnez C, et al. 2011. The genomic complexity of primary human prostate cancer. Nature 470: 214-220.
3. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, et al. 2006. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326.
4. Bird A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21. (Pubitemid 34049633)
5. Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T. 2005. BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 21: 4067-4068. (Pubitemid 41631851)
6. Bock C, Tomazou EM, Brinkman AB, Muller F, Simmer F, Gu H, Jager N, Gnirke A, Stunnenberg HG, Meissner A. 2010. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol 28: 1106-1114.
7. Bouchard D, Morisset D, Bourbonnais Y, Tremblay GM. 2006. Proteins with whey-acidic-protein motifs and cancer. Lancet Oncol 7: 167-174. (Pubitemid 43159503)
8. Brunner AL, Johnson DS, Kim SW, Valouev A, Reddy TE, Neff NF, Anton E, Medina C, Nguyen L, Chiao E, et al. 2009. Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res 19: 1044-1056.
9. Cokus SJ, Feng S, Zhang X, Chen Z,Merriman B, Haudenschild CD, Pradhan S, Nelson SF, Pellegrini M, Jacobsen SE. 2008. Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 452: 215-219. (Pubitemid 351380251)
10. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. 2000. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25: 315-319. (Pubitemid 30437320)
11. Dammann R, Schagdarsurengin U, Seidel C, Strunnikova M, Rastetter M, Baier K, Pfeifer GP. 2005. The tumor suppressor RASSF1A in human carcinogenesis: an update. Histol Histopathol 20: 645-663. (Pubitemid 40468282)
12. Down TA, Rakyan VK, Turner DJ, Flicek P, Li H, Kulesha E, Graf S, Johnson N, Herrero J, Tomazou EM, et al. 2008. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol 26: 779-785. (Pubitemid 351961453)
13. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, Burton J, Cox TV, Davies R, Down TA, et al. 2006. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 38: 1378-1385.
14. Feber A, Wilson GA, Zhang L, Presneau N, Idowu B, Down TA, Rakyan VK, Noon LA, Lloyd AC, Stupka E, et al. 2011. Comparative methylome analysis of benign and malignant peripheral nerve sheath tumours. Genome Res 21: 515-524.
15. Gebhard C, Benner C, Ehrich M, Schwarzfischer L, Schilling E, Klug M, Dietmaier W, Thiede C, Holler E, Andreesen R, et al. 2010. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. Cancer Res 70: 1398-1407.
16. Gu H, Bock C, Mikkelsen TS, Jager N, Smith ZD, Tomazou E, Gnirke A, Lander ES, Meissner A. 2010. Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution. Nat Methods 7: 133-136.
17. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. 2007. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130: 77-88. (Pubitemid 47031323)
18. Han B, Mehra R, Dhanasekaran SM, Yu J, Menon A, Lonigro RJ, Wang X, Gong Y, Wang L, Shankar S, et al. 2008. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: Identification of DDX5-ETV4 fusion protein in prostate cancer. Cancer Res 68: 7629-7637.
19. Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, Downey SL, Johnson BE, Fouse SD, Delaney A, Zhao Y, et al. 2010. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol 28: 1097-1105.
20. Hodges E, Smith A, Kendall J, Xuan Z, Ravi K, Rooks M, Zhang M, Ye K, Battacharjee A, Brizuela L, et al. 2009. High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing. Genome Res 19: 1593-1605.
21. Ibragimova I, Ibanez de Caceres I, Hoffman AM, Potapova A, Dulaimi E, Al-Saleem T, Hudes GR, Ochs MF, Cairns P. 2010. Global reactivation of epigenetically silenced genes in prostate cancer. Cancer Prev Res (Phila) 3: 1084-1092.
22. Illingworth RS, Bird AP. 2009. CpG islands-'a rough guide.' FEBS Lett 583: 1713-1720.
23. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, et al. 2009. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41: 178-186.
24. Issa JP. 2004. CpG island methylator phenotype in cancer. Nat Rev Cancer 4: 988-993.
25. Jaspers I, Horvath KM, Zhang W, Brighton LE, Carson JL, Noah TL. 2010. Reduced expression of IRF7 in nasal epithelial cells from smokers after infection with influenza. Am J Respir Cell Mol Biol 43: 368-375.
26. Jhavar S, Reid A, Clark J, Kote-Jarai Z, Christmas T, Thompson A, Woodhouse C, Ogden C, Fisher C, Corbishley C, et al. 2008. Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays. J Mol Diagn 10: 50-57. (Pubitemid 351184835)
27. Jones PA, Baylin SB. 2007. The epigenomics of cancer. Cell 128: 683-692. (Pubitemid 46273572)
28. Kim JH, Dhanasekaran SM, Mehra R, Tomlins SA, Gu W, Yu J, Kumar-Sinha C, Cao X, Dash A, Wang L, et al. 2007. Integrative analysis of genomic aberrations associated with prostate cancer progression. Cancer Res 67: 8229-8239. (Pubitemid 47395160)
29. Kron K, Pethe V, Briollais L, Sadikovic B, Ozcelik H, Sunderji A, Venkateswaran V, Pinthus J, Fleshner N, van der Kwast T, et al. 2009. Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays. PLoS ONE 4: e4830. doi: 10.1371/journal.pone.0004830.
30. Kumar-Sinha C, Tomlins SA, Chinnaiyan AM. 2008. Recurrent gene fusions in prostate cancer. Nat Rev Cancer 8: 497-511.
31. Kuzmin I, Gillespie JW, Protopopov A, Geil L, Dreijerink K, Yang Y, Vocke CD, Duh FM, Zabarovsky E, Minna JD, et al. 2002. The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Cancer Res 62: 3498-3502. (Pubitemid 34651398)
32. Laird PW. 2010. Principles and challenges of genome-wide DNA methylation analysis. Nat Rev Genet 11: 191-203.
33. Li LC, Dahiya R. 2002. MethPrimer: designing primers for methylation PCRs. Bioinformatics 18: 1427-1431. (Pubitemid 35414532)
34. Li LC, Carroll PR, Dahiya R. 2005. Epigenetic changes in prostate cancer: Implication for diagnosis and treatment. J Natl Cancer Inst 97: 103-115. (Pubitemid 40277090)
35. Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N, Chinnaiyan AM. 2009. Transcriptome sequencing to detect gene fusions in cancer. Nature 458: 97-101.
36. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, Johnson BE, Hong C, Nielsen C, Zhao Y, et al. 2010. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466: 253-257.
37. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, et al. 2008. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454: 766-770.
38. Morison IM, Ramsay JP, Spencer HG. 2005. A census of mammalian imprinting. Trends Genet 21: 457-465. (Pubitemid 40981795)
39. Nelson WG, De Marzo AM, Yegnasubramanian S. 2009. Epigenetic alterations in human prostate cancers. Endocrinology 150: 3991-4002.
40. Ongenaert M, Van Neste L, De Meyer T, Menschaert G, Bekaert S, Van Criekinge W. 2008. PubMeth: a cancer methylation database combining text-mining and expert annotation. Nucleic Acids Res 36: D842-D846. (Pubitemid 351149833)
41. Perry AS, Watson RW, Lawler M, Hollywood D. 2010. The epigenome as a therapeutic target in prostate cancer. Nat Rev Urol 7: 668-680.
42. Qin ZS, Yu J, Shen J, Maher CA, Hu M, Kalyana-Sundaram S, Chinnaiyan AM. 2010. HPeak: an HMM-based algorithm for defining read-enriched regions in ChIP-Seq data. BMC Bioinformatics 11: 369.
43. Rauch TA, Pfeifer GP. 2009. The MIRA method for DNA methylation analysis. Methods Mol Biol 507: 65-75.
44. Rauch TA,Wu X, Zhong X, Riggs AD, Pfeifer GP. 2009. A human B cell methylome at 100-base pair resolution. Proc Natl Acad Sci 106: 671-678.
45. Reuter M, Chuma S, Tanaka T, Franz T, Stark A, Pillai RS. 2009. Loss of the Mili-interacting Tudor domain-containing protein-1 activates transposons and alters the Mili-associated small RNA profile. Nat Struct Mol Biol 16: 639-646.
46. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, et al. 2007a. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9: 166-180.
47. Rhodes DR, Kalyana-Sundaram S, Tomlins SA, Mahavisno V, Kasper N, Varambally R, Barrette TR, Ghosh D, Varambally S, Chinnaiyan AM. 2007b. Molecular concepts analysis links tumors, pathways, mechanisms, and drugs. Neoplasia 9: 443-454. (Pubitemid 46799988)
48. Schummer M, Ng WV, Bumgarner RE, Nelson PS, Schummer B, Bednarski DW, Hassell L, Baldwin RL, Karlan BY, Hood L. 1999. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. Gene 238: 375-385. (Pubitemid 29446174)
49. Takai D, Jones PA. 2002. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci 99: 3740-3745. (Pubitemid 34252176)
50. Thomson JP, Skene PJ, Selfridge J, Clouaire T, Guy J, Webb S, Kerr AR, Deaton A, Andrews R, James KD, et al. 2010. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 464: 1082-1086.
51. Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, Menon A, Jing X, Cao Q, Han B, et al. 2007a. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448: 595-599. (Pubitemid 47206938)
52. Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, et al. 2007b. Integrative molecular concept modeling of prostate cancer progression. Nat Genet 39: 41-51. (Pubitemid 46026500)
53. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci 98: 5116-5121. (Pubitemid 32397092)
54. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RTPCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034. doi: 10.1186/gb-2002-3-7-research0034.
55. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D. 2005. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37: 853-862. (Pubitemid 41077111)
56. Wu H, Coskun V, Tao J, Xie W, Ge W, Yoshikawa K, Li E, Zhang Y, Sun YE. 2010. Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes. Science 329: 444-448.
57. Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, Walsh PC, Bova GS, De Marzo AM, Isaacs WB, Nelson WG. 2004. Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 64: 1975-1986. (Pubitemid 38339443)
58. Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, Irizarry RA, Morgan J, Hicks J, DeWeese TL, et al. 2008. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res 68: 8954-8967.
59. Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, Gong Y, et al. 2010. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 17: 443-454.